These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36907909)

  • 21. Community Use of Face Masks against the Spread of COVID-19.
    Bubbico L; Mastrangelo G; Larese-Filon F; Basso P; Rigoli R; Maurelli M; Ferlito S; Capelli M; Gisabella C; Javanbakht M; Bellizzi S; Cegolon L
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33808861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of Agarose-aided Sprays to the Posterior Nose for Mucosa Immunization and Short-term Protection against Infectious Respiratory Diseases.
    Seifelnasr A; Talaat M; Si XA; Xi J
    Curr Pharm Biotechnol; 2024; 25(6):787-798. PubMed ID: 37533243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II Trial of the Impact 0.5% Povidone-Iodine Nasal Spray (Nasodine®) on Shedding of SARS-CoV-2.
    Friedland PL; Tucker S
    Laryngoscope; 2024 Sep; 134(9):3947-3952. PubMed ID: 38554057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection.
    Winchester S; John S; Jabbar K; John I
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 33992687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simulating near-field enhancement in transmission of airborne viruses with a quadrature-based model.
    Fierce L; Robey AJ; Hamilton C
    Indoor Air; 2021 Nov; 31(6):1843-1859. PubMed ID: 34297863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
    Belser JA; Sun X; Kieran TJ; Brock N; Pulit-Penaloza JA; Pappas C; Basu Thakur P; Jones J; Wentworth DE; Zhou B; Tumpey TM; Maines TR
    J Virol; 2022 Dec; 96(24):e0140322. PubMed ID: 36448801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal spray of an IgM-like ACE2 fusion protein HH-120 accelerates SARS-CoV-2 clearance: A single-center propensity score-matched cohort study.
    Song R; Chen X; Li B; Zhang H; Guo X; Liu Z; Zou L; Liang X; Lei C; Mao F; Sui J; Li W; Jin R
    J Med Virol; 2023 May; 95(5):e28805. PubMed ID: 37227062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial.
    Castellarnau A; Heery GP; Seta A; Luscombe CA; Kinghorn GR; Button P; McCloud P; Paull JRA
    Sci Rep; 2022 Jun; 12(1):10210. PubMed ID: 35715644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Povidone-Iodine Nasal Spray on Nasopharyngeal SARS-CoV-2 Viral Load: A Randomized Control Trial.
    Zarabanda D; Vukkadala N; Phillips KM; Qian ZJ; Mfuh KO; Hatter MJ; Lee IT; Rao VK; Hwang PH; Domb G; Patel ZM; Pinsky BA; Nayak JV
    Laryngoscope; 2022 Nov; 132(11):2089-2095. PubMed ID: 34724213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.
    Idris A; Supramaniam A; Tayyar Y; Kelly G; McMillan NAJ; Morris KV
    Antiviral Res; 2024 Feb; 222():105815. PubMed ID: 38246206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds.
    Lee BU
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial.
    Little P; Vennik J; Rumsby K; Stuart B; Becque T; Moore M; Francis N; Hay AD; Verheij T; Bradbury K; Greenwell K; Dennison L; Holt S; Denison-Day J; Ainsworth B; Raftery J; Thomas T; Butler CC; Richards-Hall S; Smith D; Patel H; Williams S; Barnett J; Middleton K; Miller S; Johnson S; Nuttall J; Webley F; Sach T; Yardley L; Geraghty AWA
    Lancet Respir Med; 2024 Aug; 12(8):619-632. PubMed ID: 39004091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric Oxide and its Derivatives Containing Nasal Spray and Inhalation Therapy for the Treatment of COVID-19.
    Chavda VP; Patel AB; Vora LK; Singla RK; Shah P; Uversky VN; Apostolopoulos V
    Curr Pharm Des; 2022; 28(46):3658-3670. PubMed ID: 36284382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.
    Konrat R; Papp H; Kimpel J; Rössler A; Szijártó V; Nagy G; Madai M; Zeghbib S; Kuczmog A; Lanszki Z; Gesell T; Helyes Z; Kemenesi G; Jakab F; Nagy E
    Front Pharmacol; 2022; 13():861295. PubMed ID: 35846988
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection.
    Burton MJ; Clarkson JE; Goulao B; Glenny AM; McBain AJ; Schilder AG; Webster KE; Worthington HV
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013626. PubMed ID: 32936949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis-ICE-COVID.
    Jessop ZM; Gibson J; Lim JY; Jovic TH; Combellack E; Dobbs TD; Carter K; Hiles S; Islam S; Healy B; Humphreys I; Eccles R; Hutchings HA; Whitaker IS
    Trials; 2022 Sep; 23(1):782. PubMed ID: 36109791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aerosol Dynamics Model for Estimating the Risk from Short-Range Airborne Transmission and Inhalation of Expiratory Droplets of SARS-CoV-2.
    Dhawan S; Biswas P
    Environ Sci Technol; 2021 Jul; 55(13):8987-8999. PubMed ID: 34132519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles.
    Madas BG; Füri P; Farkas Á; Nagy A; Czitrovszky A; Balásházy I; Schay GG; Horváth A
    Sci Rep; 2020 Dec; 10(1):22430. PubMed ID: 33384436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts.
    Warnken ZN; Smyth HDC; Davis DA; Weitman S; Kuhn JG; Williams RO
    Mol Pharm; 2018 Apr; 15(4):1392-1402. PubMed ID: 29485888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.